Is adenomyomatosis of the gallbladder (GB) a malignant condition?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Adenomyomatosis of the Gallbladder Malignant?

Adenomyomatosis of the gallbladder is a benign condition, not a malignancy. 1

What Adenomyomatosis Actually Is

Adenomyomatosis is defined as mural hyperplasia (benign overgrowth of the gallbladder wall) that may be diffuse, focal, or segmental, characterized by:

  • Rokitansky-Aschoff sinuses (intramural cysts/diverticula) 1
  • Comet-tail artifact on gray-scale ultrasound or twinkling artifact on color Doppler imaging due to intramural cholesterol crystals 1
  • Wall thickening containing small bile-filled cystic spaces 2

This is fundamentally a hyperplastic benign disease, not a neoplastic or malignant process. 3, 4

Critical Distinction from Malignancy

The Society of Radiologists in Ultrasound 2022 guidelines explicitly categorize adenomyomatosis as a benign entity that must be distinguished from true gallbladder polyps and malignancies. 1

Key differentiating features:

  • Adenomyomatosis shows characteristic imaging artifacts (comet-tail, twinkling) that gallbladder cancer does not 1, 5
  • At contrast-enhanced ultrasound (CEUS), adenomyomatosis demonstrates avascular Rokitansky-Aschoff sinuses, unlike the marked early enhancement seen in neoplastic lesions 5, 2
  • MRI shows the pathognomonic "pearl necklace" appearance of Rokitansky-Aschoff sinuses 4

The Controversial Association with Cancer

Important caveat: While adenomyomatosis itself is benign, there is emerging evidence of a potential association with gallbladder cancer development:

  • Some studies suggest adenomyomatosis may predispose to gallbladder malignancies, though this remains controversial 3, 6
  • One study found that 25.8% of surgically treated gallbladder carcinomas had gross features of adenomyomatosis, and these cancers were more often diagnosed at advanced stages 7
  • The hypothesis is that preceding adenomyomatosis may mask early detection of gallbladder cancer rather than directly causing malignancy 7

However, adenomyomatosis is still classified as a benign condition despite these reports. 3

Management Approach

For symptomatic adenomyomatosis:

  • Cholecystectomy is indicated and results in complete symptom resolution 3, 4

For asymptomatic adenomyomatosis:

  • No surgery required if the radiological diagnosis is certain 4
  • Wait-and-see policy is viable for low-risk patterns (particularly fundal type) with scheduled follow-ups 3
  • Exception: If there is any diagnostic doubt about possible gallbladder cancer, cholecystectomy is justified 6, 4

Patterns requiring heightened vigilance:

  • Segmental type adenomyomatosis was associated with 64% of adenomyomatosis-positive gallbladder cancers in one series 7
  • Diffuse type appears less concerning 7

Bottom Line

Adenomyomatosis is definitively benign, but the diagnostic certainty must be absolute—if imaging cannot confidently exclude malignancy, surgical resection is warranted. 6, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Stepwise approach and surgery for gallbladder adenomyomatosis: a mini-review.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2013

Research

Gallbladder adenomyomatosis: Diagnosis and management.

Journal of visceral surgery, 2017

Guideline

Imaging Approach for Suspected Gallbladder Polyp

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinicopathologic features of advanced gallbladder cancer associated with adenomyomatosis.

Virchows Archiv : an international journal of pathology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.